胃食道癌和功能的手术前飞疗法:一个新的瘤脏学视角
Kidney & blood pressure research
|April 9, 2025
概括
在胃癌患者的FLOT治疗方案中,急性病 (AKD) 不常见. 口服抗糖尿病药物和前列腺缩可能预测AKD风险,需要在治疗期间仔细监测脏.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學.
- 临床药理学 临床药理学
背景情况:
- FLOT疗法 (甲,莱可沃林,甲,多塞塔克塞尔) 是胃和食管胃结癌的标准治疗方案.
- 由于人们对FLOT疗法对脏有毒性的担忧,因此需要进一步调查其实际发生率和风险因素.
研究的目的:
- 评估FLOT治疗方案的毒性概况,特别关注急性病 (AKD) 的发生.
- 在接受新辅助FLOT治疗的患者中识别与AKD相关的潜在风险因素.
主要方法:
- 进行了一项多中心的回顾性研究.
- 分析了接受新辅助药FLOT治疗的96名患者的数据,以确定AKD发病率和相关风险因素.
主要成果:
- 3名患者发生了急性病 (AKD),随访月均发生率为0.0122例.
- 使用口服抗糖尿病药物和前列腺缩的存在被确定为AKD的显著预测因素.
结论:
- 新辅助性FLOT治疗与急性脏疾病的发病率较低有关.
- 对于接受FLOT治疗的患者来说,勤奋的功能监测和预防策略至关重要.
- 需要对更大的群体进行进一步的研究,包括那些基线 eGFR 较低的人群.
相关概念视频
Renal Failure: Dose Adjustments
38
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
38
Factors Affecting Renal Clearance: Renal Impairment
36
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
36
Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
329
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
329
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
147
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
147
Renal Drug Excretion: Tubular Secretion
98
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
98


